Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to ...

A lot of older adults also need protection against another risky winter virus, RSV. Yes, you can get your ... 2 while the Novavax vaccine targets its parent strain, JN.1. Daskalakis said all ...

Patients who are also entitled to the respiratory syncytial virus (RSV ... A protein-based booster vaccine made by Novavax, which works differently to the Pfizer and Moderna jabs, is also available.

TORONTO — Health Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older — but it won't be available until next year, the company ...

A lot of older adults also need protection against another risky winter virus, RSV. Yes, you can get your ... 2 while the Novavax vaccine targets its parent strain, JN.1. Daskalakis said all ...

Go to source) for newborns and pregnant women. Mark Butler, the minister for health, announced 174.5 million Australian dollars ($114.8 million) in funding to subsidize RSV vaccinations following ...

Moderna said on Friday that Canada’s health regulator has approved its vaccine for respiratory syncytial virus (RSV) in adults 60 years and older, making it the country’s first authorized mRNA ...

Moderna’s (NASDAQ:MRNA) Q3 results confirmed on Thursday that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (NYSE:PFE) and GSK (NYSE:GSK), is shrinking.